Novo Nordisk Slide Decks - Search News

News

Novo Nordisk slides

Bloomberg · 2d

Novo Nordisk Slides on Pressure From Lilly’s Pill Study

Novo Nordisk A/S slumped after a pill from rival Eli Lilly & Co. helped patients shed weight and control blood sugar about as well as its injected blockbuster Ozempic.

The Motley Fool on MSN · 6d

Why Eli Lilly Stock Is Soaring Today, While Novo Nordisk and Viking Therapeutics Slide

Lilly shares are up 14.2% in response to the news, while shares of its rivals in the GLP-1 weight loss market, Novo Nordisk ( NVO -1.24%) and Viking Therapeutics ( VKTX 1.04%), are falling 7.1% and 1.7%, respectively.

Seeking Alpha on MSN · 2d

Novo Nordisk slides after Eli Lilly's results for oral weight loss drug—orforglipron

Novo Nordisk's (NVO) stock price dropped following Eli Lilly's announcement of positive Phase 3 trial results for its oral weight loss drug orforglipron—that helped patients shed weight and control blood sugar,

14d

Novo Nordisk, AbbVie Stocks Slide After Trump Vows Pharma Tariffs

Stocks in drugmakers sold off globally after President Trump said tariffs on pharmaceutical imports will be unveiled shortly, ...

1monon MSN

Novo Nordisk shares slide 6% after weight loss drug trial disappoints

Novo Nordisk shares declined on Monday after the company reported that its next-generation weight-loss drug, CagriSema, ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results